CPhI Online

Stevanato Group and Bexson Biomedical announce collaboration to develop a customized wearable ketamine delivery device

28 Sep 2020

Patients suffering from chronic and acute pain disorders will benefit from a convenient, discreet, and easy-to-use device delivering a novel alternative to opioid-based pain management.

Read More